Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia

Georgios Papazisis, Chryssa Pourzitaki, Chrysanthi Sardeli, Aimilios Lallas, Ekaterini Amaniti, Dimitrios Kouvelas

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Hypoxic-ischemic encephalopathy is a severe complication of perinatal asphyxia and causes lifelong deficits in infants and children. Multiple mechanisms acting in serial or parallel fashion are likely to be involved in this procedure. The neuronal injury is strongly related to iron-catalysed oxygen radical production and subsequent peroxidative damage to lipids and protein. Excessive release of excitatory amino acids (EAA) glutamate and aspartate, with consequent overstimulation of glutamate receptors, is also thought to be an important mechanism in this brain injury. Deferoxamine (DFO), a chelator of non-protein-bound iron, has been shown to inhibit lipid peroxidation and hydroxyl radical production via the Fenton reaction and to decrease hypoxic-ischemic and reperfusion associated brain injury. However, the exact mechanism of neuroprotection of DFO and its possible effect on the neurotransmitters' release is currently being investigated. In the present study, a well-established model of perinatal asphyxia was used to investigate the effect of DFO on hypoxic-ischemic-induced damage to different hippocampal brain structures. DFO was administrated subcutaneously immediately after the asphyctic insult. Histological examination of the hippocampus was conducted and the tissue levels of glutamate and aspartate in the same area were determined. A remarkable reduction of hypoxia-ischemia-evoked neurons in the CA1 hippocampal region and a decrease in the asphyxia-induced hippocampal tissue levels of glutamate and aspartate was noted after DFO treatment. These findings suggest a complex action of DFO, which could be neuroprotective when administrated in the immature brain immediately after hypoxia-ischemia.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalPharmacological Research
Volume57
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Excitatory Amino Acids
Deferoxamine
Hippocampus
Ischemia
Asphyxia
Aspartic Acid
Glutamic Acid
Brain Injuries
Iron
Brain Hypoxia-Ischemia
Hippocampal CA1 Region
Glutamate Receptors
Brain
Chelating Agents
Hydroxyl Radical
Lipid Peroxidation
Reperfusion
Neurotransmitter Agents
Hypoxia
Reactive Oxygen Species

Keywords

  • Deferoxamine
  • Excitatory amino acids
  • Hypoxia-ischemia
  • Neonatal rats
  • Neuroprotection

ASJC Scopus subject areas

  • Pharmacology

Cite this

Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. / Papazisis, Georgios; Pourzitaki, Chryssa; Sardeli, Chrysanthi; Lallas, Aimilios; Amaniti, Ekaterini; Kouvelas, Dimitrios.

In: Pharmacological Research, Vol. 57, No. 1, 01.2008, p. 73-78.

Research output: Contribution to journalArticle

Papazisis, Georgios ; Pourzitaki, Chryssa ; Sardeli, Chrysanthi ; Lallas, Aimilios ; Amaniti, Ekaterini ; Kouvelas, Dimitrios. / Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. In: Pharmacological Research. 2008 ; Vol. 57, No. 1. pp. 73-78.
@article{8e208e49bdb541569a10df257d9c7af2,
title = "Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia",
abstract = "Hypoxic-ischemic encephalopathy is a severe complication of perinatal asphyxia and causes lifelong deficits in infants and children. Multiple mechanisms acting in serial or parallel fashion are likely to be involved in this procedure. The neuronal injury is strongly related to iron-catalysed oxygen radical production and subsequent peroxidative damage to lipids and protein. Excessive release of excitatory amino acids (EAA) glutamate and aspartate, with consequent overstimulation of glutamate receptors, is also thought to be an important mechanism in this brain injury. Deferoxamine (DFO), a chelator of non-protein-bound iron, has been shown to inhibit lipid peroxidation and hydroxyl radical production via the Fenton reaction and to decrease hypoxic-ischemic and reperfusion associated brain injury. However, the exact mechanism of neuroprotection of DFO and its possible effect on the neurotransmitters' release is currently being investigated. In the present study, a well-established model of perinatal asphyxia was used to investigate the effect of DFO on hypoxic-ischemic-induced damage to different hippocampal brain structures. DFO was administrated subcutaneously immediately after the asphyctic insult. Histological examination of the hippocampus was conducted and the tissue levels of glutamate and aspartate in the same area were determined. A remarkable reduction of hypoxia-ischemia-evoked neurons in the CA1 hippocampal region and a decrease in the asphyxia-induced hippocampal tissue levels of glutamate and aspartate was noted after DFO treatment. These findings suggest a complex action of DFO, which could be neuroprotective when administrated in the immature brain immediately after hypoxia-ischemia.",
keywords = "Deferoxamine, Excitatory amino acids, Hypoxia-ischemia, Neonatal rats, Neuroprotection",
author = "Georgios Papazisis and Chryssa Pourzitaki and Chrysanthi Sardeli and Aimilios Lallas and Ekaterini Amaniti and Dimitrios Kouvelas",
year = "2008",
month = "1",
doi = "10.1016/j.phrs.2007.12.003",
language = "English",
volume = "57",
pages = "73--78",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "1",

}

TY - JOUR

T1 - Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia

AU - Papazisis, Georgios

AU - Pourzitaki, Chryssa

AU - Sardeli, Chrysanthi

AU - Lallas, Aimilios

AU - Amaniti, Ekaterini

AU - Kouvelas, Dimitrios

PY - 2008/1

Y1 - 2008/1

N2 - Hypoxic-ischemic encephalopathy is a severe complication of perinatal asphyxia and causes lifelong deficits in infants and children. Multiple mechanisms acting in serial or parallel fashion are likely to be involved in this procedure. The neuronal injury is strongly related to iron-catalysed oxygen radical production and subsequent peroxidative damage to lipids and protein. Excessive release of excitatory amino acids (EAA) glutamate and aspartate, with consequent overstimulation of glutamate receptors, is also thought to be an important mechanism in this brain injury. Deferoxamine (DFO), a chelator of non-protein-bound iron, has been shown to inhibit lipid peroxidation and hydroxyl radical production via the Fenton reaction and to decrease hypoxic-ischemic and reperfusion associated brain injury. However, the exact mechanism of neuroprotection of DFO and its possible effect on the neurotransmitters' release is currently being investigated. In the present study, a well-established model of perinatal asphyxia was used to investigate the effect of DFO on hypoxic-ischemic-induced damage to different hippocampal brain structures. DFO was administrated subcutaneously immediately after the asphyctic insult. Histological examination of the hippocampus was conducted and the tissue levels of glutamate and aspartate in the same area were determined. A remarkable reduction of hypoxia-ischemia-evoked neurons in the CA1 hippocampal region and a decrease in the asphyxia-induced hippocampal tissue levels of glutamate and aspartate was noted after DFO treatment. These findings suggest a complex action of DFO, which could be neuroprotective when administrated in the immature brain immediately after hypoxia-ischemia.

AB - Hypoxic-ischemic encephalopathy is a severe complication of perinatal asphyxia and causes lifelong deficits in infants and children. Multiple mechanisms acting in serial or parallel fashion are likely to be involved in this procedure. The neuronal injury is strongly related to iron-catalysed oxygen radical production and subsequent peroxidative damage to lipids and protein. Excessive release of excitatory amino acids (EAA) glutamate and aspartate, with consequent overstimulation of glutamate receptors, is also thought to be an important mechanism in this brain injury. Deferoxamine (DFO), a chelator of non-protein-bound iron, has been shown to inhibit lipid peroxidation and hydroxyl radical production via the Fenton reaction and to decrease hypoxic-ischemic and reperfusion associated brain injury. However, the exact mechanism of neuroprotection of DFO and its possible effect on the neurotransmitters' release is currently being investigated. In the present study, a well-established model of perinatal asphyxia was used to investigate the effect of DFO on hypoxic-ischemic-induced damage to different hippocampal brain structures. DFO was administrated subcutaneously immediately after the asphyctic insult. Histological examination of the hippocampus was conducted and the tissue levels of glutamate and aspartate in the same area were determined. A remarkable reduction of hypoxia-ischemia-evoked neurons in the CA1 hippocampal region and a decrease in the asphyxia-induced hippocampal tissue levels of glutamate and aspartate was noted after DFO treatment. These findings suggest a complex action of DFO, which could be neuroprotective when administrated in the immature brain immediately after hypoxia-ischemia.

KW - Deferoxamine

KW - Excitatory amino acids

KW - Hypoxia-ischemia

KW - Neonatal rats

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=39149123465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149123465&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2007.12.003

DO - 10.1016/j.phrs.2007.12.003

M3 - Article

C2 - 18243015

AN - SCOPUS:39149123465

VL - 57

SP - 73

EP - 78

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 1

ER -